cbdMD (YCBD) Net Income Growth (3y) (2019 - 2025)
cbdMD (YCBD) Net Income Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -17.90% |
| 10 | cbdMD | 4.57 Mn | 1.18 Mn | 3.00 Mn | 58.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.48% |
| Sep 30, 2025 | 64.05% |
| Jun 30, 2025 | 69.53% |
| Mar 31, 2025 | 53.09% |
| Dec 31, 2024 | 26.01% |
| Jun 30, 2023 | -510.49% |
| Dec 31, 2022 | -357.91% |
| Sep 30, 2022 | -81.06% |
| Jun 30, 2022 | -140.65% |
| Mar 31, 2022 | -1,876.85% |
| Dec 31, 2021 | -301.91% |
| Jun 30, 2020 | 72.43% |
| Dec 31, 2019 | 58.23% |